NCT03069352 · BASELINE
Baseline characteristics
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- denoms
- counts
- group Id
- BG000
- value
- 68
- group Id
- BG001
- value
- 143
- group Id
- BG002
- value
- 211
- units
- Participants
- groups
- description
- Participants received matching placebo to venetoclax orally once a day (QD) plus cytarabine 20 mg/m² subcutaneously on Days 1 to 10 of each 28-day cycle.
- id
- BG000
- title
- Placebo + Low Dose Cytarabine (LDAC)
- description
- Participants received venetoclax 600 mg orally once a day plus cytarabine 20 mg/m² subcutaneously on Days 1 to 10 of each 28-day cycle.
- id
- BG001
- title
- Venetoclax + Low Dose Cytarabine (LDAC)
- description
- Total of all reporting groups
- id
- BG002
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- lower Limit
- 41.0
- upper Limit
- 88.0
- value
- 76.0
- group Id
- BG001
- lower Limit
- 36.0
- upper Limit
- 93.0
- value
- 76.0
- group Id
- BG002
- lower Limit
- 36.0
- upper Limit
- 93.0
- value
- 76.0
- dispersion Type
- FULL_RANGE
- param Type
- MEDIAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 9
- group Id
- BG001
- value
- 11
- group Id
- BG002
- value
- 20
- title
- 18 to < 65 years
- measurements
- group Id
- BG000
- value
- 19
- group Id
- BG001
- value
- 50
- group Id
- BG002
- value
- 69
- title
- 65 to < 75 years
- measurements
- group Id
- BG000
- value
- 40
- group Id
- BG001
- value
- 82
- group Id
- BG002
- value
- 122
- title
- ≥ 75 years
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Age, Customized
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 29
- group Id
- BG001
- value
- 65
- group Id
- BG002
- value
- 94
- title
- Female
- measurements
- group Id
- BG000
- value
- 39
- group Id
- BG001
- value
- 78
- group Id
- BG002
- value
- 117
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 47
- group Id
- BG001
- value
- 102
- group Id
- BG002
- value
- 149
- title
- White
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 2
- group Id
- BG002
- value
- 3
- title
- Black or African American
- measurements
- group Id
- BG000
- value
- 20
- group Id
- BG001
- value
- 39
- group Id
- BG002
- value
- 59
- title
- Asian
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race/Ethnicity, Customized
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 6
- group Id
- BG001
- value
- 13
- group Id
- BG002
- value
- 19
- title
- United States
- measurements
- group Id
- BG000
- value
- 26
- group Id
- BG001
- value
- 56
- group Id
- BG002
- value
- 82
- title
- European Union
- measurements
- group Id
- BG000
- value
- 6
- group Id
- BG001
- value
- 9
- group Id
- BG002
- value
- 15
- title
- China
- measurements
- group Id
- BG000
- value
- 9
- group Id
- BG001
- value
- 18
- group Id
- BG002
- value
- 27
- title
- Japan
- measurements
- group Id
- BG000
- value
- 21
- group Id
- BG001
- value
- 47
- group Id
- BG002
- value
- 68
- title
- Rest of World
- description
- Rest of World includes Australia, Brazil, Canada, New Zealand, Puerto Rico, Russia, South Africa, South Korea, and Taiwan.
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Region
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 45
- group Id
- BG001
- value
- 85
- group Id
- BG002
- value
- 130
- title
- De novo
- measurements
- group Id
- BG000
- value
- 23
- group Id
- BG001
- value
- 58
- group Id
- BG002
- value
- 81
- title
- Secondary
- param Type
- COUNT_OF_PARTICIPANTS
- title
- AML Status
- unit Of Measure
- Participants
Complete source fields
- denoms
- counts
- group Id
- BG000
- value
- 68
- group Id
- BG001
- value
- 143
- group Id
- BG002
- value
- 211
- units
- Participants
- groups
- description
- Participants received matching placebo to venetoclax orally once a day (QD) plus cytarabine 20 mg/m² subcutaneously on Days 1 to 10 of each 28-day cycle.
- id
- BG000
- title
- Placebo + Low Dose Cytarabine (LDAC)
- description
- Participants received venetoclax 600 mg orally once a day plus cytarabine 20 mg/m² subcutaneously on Days 1 to 10 of each 28-day cycle.
- id
- BG001
- title
- Venetoclax + Low Dose Cytarabine (LDAC)
- description
- Total of all reporting groups
- id
- BG002
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- lower Limit
- 41.0
- upper Limit
- 88.0
- value
- 76.0
- group Id
- BG001
- lower Limit
- 36.0
- upper Limit
- 93.0
- value
- 76.0
- group Id
- BG002
- lower Limit
- 36.0
- upper Limit
- 93.0
- value
- 76.0
- dispersion Type
- FULL_RANGE
- param Type
- MEDIAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 9
- group Id
- BG001
- value
- 11
- group Id
- BG002
- value
- 20
- title
- 18 to < 65 years
- measurements
- group Id
- BG000
- value
- 19
- group Id
- BG001
- value
- 50
- group Id
- BG002
- value
- 69
- title
- 65 to < 75 years
- measurements
- group Id
- BG000
- value
- 40
- group Id
- BG001
- value
- 82
- group Id
- BG002
- value
- 122
- title
- ≥ 75 years
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Age, Customized
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 29
- group Id
- BG001
- value
- 65
- group Id
- BG002
- value
- 94
- title
- Female
- measurements
- group Id
- BG000
- value
- 39
- group Id
- BG001
- value
- 78
- group Id
- BG002
- value
- 117
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 47
- group Id
- BG001
- value
- 102
- group Id
- BG002
- value
- 149
- title
- White
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 2
- group Id
- BG002
- value
- 3
- title
- Black or African American
- measurements
- group Id
- BG000
- value
- 20
- group Id
- BG001
- value
- 39
- group Id
- BG002
- value
- 59
- title
- Asian
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race/Ethnicity, Customized
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 6
- group Id
- BG001
- value
- 13
- group Id
- BG002
- value
- 19
- title
- United States
- measurements
- group Id
- BG000
- value
- 26
- group Id
- BG001
- value
- 56
- group Id
- BG002
- value
- 82
- title
- European Union
- measurements
- group Id
- BG000
- value
- 6
- group Id
- BG001
- value
- 9
- group Id
- BG002
- value
- 15
- title
- China
- measurements
- group Id
- BG000
- value
- 9
- group Id
- BG001
- value
- 18
- group Id
- BG002
- value
- 27
- title
- Japan
- measurements
- group Id
- BG000
- value
- 21
- group Id
- BG001
- value
- 47
- group Id
- BG002
- value
- 68
- title
- Rest of World
- description
- Rest of World includes Australia, Brazil, Canada, New Zealand, Puerto Rico, Russia, South Africa, South Korea, and Taiwan.
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Region
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 45
- group Id
- BG001
- value
- 85
- group Id
- BG002
- value
- 130
- title
- De novo
- measurements
- group Id
- BG000
- value
- 23
- group Id
- BG001
- value
- 58
- group Id
- BG002
- value
- 81
- title
- Secondary
- param Type
- COUNT_OF_PARTICIPANTS
- title
- AML Status
- unit Of Measure
- Participants
Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0
Preserved source evidence · Not medical advice
Triangle